Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics

Abul K Azad1, Murugesan V S Rajaram1, Larry S Schlesinger1

  • 1Center for Microbial Interface Biology and the Department of Microbial Infection and Immunity, The Ohio State University, USA.

Journal of Cytology & Molecular Biology
|March 28, 2014
PubMed

Insights

The macrophage mannose receptor (MR, CD206) targets pathogens and is highly expressed in disease sites. Optimizing MR-mediated uptake by macrophages offers a promising strategy for diagnosing and treating chronic infections.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathogen Recognition

Background:

  • The macrophage mannose receptor (MR, CD206) is a C-type lectin found on macrophages, dendritic cells, and other cells.
  • MR plays a key role in immune homeostasis through endocytosis and phagocytosis of mannoglycoproteins.
  • MR is highly expressed at disease sites, including the tumor microenvironment, and recognizes microbial mannan structures.

Purpose of the Study:

  • To review progress in optimizing MR-mediated uptake by macrophages.
  • To highlight the potential of MR targeting for diagnosis and treatment of chronic infectious diseases.

Main Methods:

  • Review of existing literature on macrophage mannose receptor function and targeting strategies.
  • Analysis of MR's role in pathogen recognition and disease pathology.

Main Results:

  • MR recognizes microbial mannan structures, which is exploited by pathogens like *Mycobacterium tuberculosis*.
  • High MR expression in pathological conditions like the tumor microenvironment is noted.
  • Targeting MR for enhanced macrophage uptake is an emerging strategy for drug delivery.

Conclusions:

  • MR-mediated uptake presents an attractive approach for targeting macrophages in infected tissues.
  • Further development in MR-targeting strategies is crucial for effective diagnosis and treatment of chronic infectious diseases.

Related Concept Videos